Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, February 7, 2019

CT matches MRI for late-window stroke evaluation

 For your hospital to write a stroke protocol on. You do expect your hospital to be completely up-to-date on stroke, Don't you?

CT matches MRI for late-window stroke evaluation

By Abraham Kim, AuntMinnie.com staff writer

February 6, 2019 -- Stroke patients who underwent endovascular therapy had similar improvement after their treatment regardless of the type of perfusion imaging -- CT or MRI -- that clinicians used to confirm their eligibility for surgical procedures, according to an article published online January 28 in JAMA Neurology.





Several recent studies using perfusion imaging to examine stroke patients, including the Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3 (DEFUSE 3) trial, have affirmed that the time window for effective surgical treatment of stroke could be safely extended by several hours after stroke onset.
These reports have led the American Heart Association and the American Stroke Association to change their stroke therapy guidelines, which now give a level 1A recommendation for thrombectomy up to 16 hours after a stroke. Following this change, clinicians have begun to investigate the extent to which postsurgical outcomes could be affected by different variables such as patient age and the type of imaging exam the patients undergo.
"As these findings are translated into clinical practice, a fundamental question is whether ... MRI or CT perfusion is the optimal imaging modality for evaluation of late-window patients," wrote Dr. Maarten Lansberg, PhD, from Stanford University and colleagues.
In a secondary analysis of data from the DEFUSE 3 trial, Lansberg and colleagues examined the 90-day outcome of 182 stroke patients who received endovascular therapy. The median age of the patients was 70 years, 51% were women, and all of them underwent either perfusion MRI or perfusion CT to confirm that they had sufficient amounts of salvageable tissue to make surgery viable.
The researchers determined that the best independent predictors of improved functional outcome 90 days after surgery were younger age, lower baseline National Institutes of Health Stroke Scale score, and lower blood glucose level. In addition, they found that the improvements in functional outcome were nearly the same for patients who waited longer for treatment (within the 16-hour window) and for those who underwent CT instead of MRI.

Perfusion MRI vs. perfusion CT for stroke evaluation
Perfusion MRI Perfusion CT
Odds ratio for improved outcome after surgery* 11.9 6.1
Median stroke onset-to-imaging time 10 hours, 33 minutes 11 hours, 3 minutes
*The difference was not statistically significant.
Overall, the proportional benefit of endovascular therapy was uniform across patients of various ages regardless of the symptom severity, time to treatment, location of occlusion, and type of perfusion imaging they underwent, the authors noted. Patients benefited from endovascular therapy whether they underwent perfusion CT or perfusion MRI to determine their eligibility for surgery, indicating that either modality could be used for patient selection.
"Endovascular therapy in the 6- to 16-hour time window among patients with evidence of salvageable tissue on brain perfusion imaging is beneficial in a broad patient population, including patients who range in age from 23 to 90 years, who have mild or severe symptoms ... [and] who are selected by CT or MRI," they wrote.

No comments:

Post a Comment